{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T12:24:25Z","timestamp":1788006265508,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:p>The risk of stroke in children screened with transcranial Doppler ultrasound in the United Kingdom is not known. We evaluated a clinician-led program using a risk assessment modified from the STOP protocol. High-risk classification included abnormal velocities in the anterior cerebral artery, and single abnormal scan if initial velocity &gt;220 cm\/s (high abnormal) or if preceded by at least 2 conditional scans. In total, 1653 scans were performed in 542 children, followed for 2235 patient-years. Fifty-eight (10.7%) high-risk subjects were identified, including 18 (31%) with high abnormal, and 15 (26%) with previous conditional scans. In 2 (3%), abnormal velocity was restricted to the anterior cerebral artery. The estimated proportion of children at high risk, scanned before 6 years of age was &gt;20%. There were 4 cases of acute ischemic stroke (AIS) and 2 of acute hemorrhagic stroke. The incidence of all stroke, AIS, and acute hemorrhagic stroke were 0.27, 0.18, and 0.09 per 100 patient-years, respectively. The proportion of children at high risk is higher than most previous estimates, partly as a result of our modified risk assessment. About 2 children per 1000 screened with transcranial Doppler ultrasound progress to AIS.<\/jats:p>","DOI":"10.1097\/mph.0000000000000633","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T11:19:37Z","timestamp":1467631177000},"page":"517-524","source":"Crossref","is-referenced-by-count":5,"title":["Transcranial Doppler Screening in a Regional Care Network for Sickle Cell Disease in the United Kingdom"],"prefix":"10.1097","volume":"38","author":[{"given":"Paul","family":"Telfer","sequence":"first","affiliation":[{"name":"Center for Genomics and Child Health, Barts and The London School of Medicine, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Dwan","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Simmons","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Evanson","sequence":"additional","affiliation":[{"name":"Neuroradiology, Royal London Hospital, Barts Health NHS Trust, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimze","family":"Gadong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Newham University Hospital, Barts Health NHS Trust, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Newell","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekayi","family":"Tangayi","sequence":"additional","affiliation":[{"name":"Newham Sickle Cell and Thalassemia Community Centre, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Leigh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Whipps Cross University Hospital, Barts Health NHS Trust, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Tsouana","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Basildon University Hospital NHS Trust, Basildon, Essex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hemmaway","sequence":"additional","affiliation":[{"name":"Department of Hematology, Queens Hospital, Romford NHS Trust, Romford, Essex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Kaya","sequence":"additional","affiliation":[{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3476(05)80897-2","article-title":"Stroke in a cohort of patients with homozygous sickle cell disease","volume":"120","author":"Balkaran","year":"1992","journal-title":"J Pediatr"},{"key":"R2-20230918","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.410420505","article-title":"Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler","volume":"42","author":"Adams","year":"1997","journal-title":"Ann Neurol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2141.2006.06193.x","article-title":"Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial","volume":"134","author":"Kwiatkowski","year":"2006","journal-title":"Br J Haematol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00247-005-1409-7","article-title":"TCD in sickle cell disease: an important and useful test","volume":"35","author":"Adams","year":"2005","journal-title":"Pediatr Radiol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2010-06-293514","article-title":"Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort","volume":"117","author":"Bernaudin","year":"2011","journal-title":"Blood"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2003-08-2733","article-title":"Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study","volume":"103","author":"Adams","year":"2004","journal-title":"Blood"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2141.2008.07167.x","article-title":"The natural history of conditional transcranial Doppler flow velocities in children with sickle cell anaemia","volume":"142","author":"Hankins","year":"2008","journal-title":"Br J Haematol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpeds.2010.03.007","article-title":"Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease","volume":"157","author":"Enninful-Eghan","year":"2010","journal-title":"J Pediatr"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.0b013e3181a110da","article-title":"Utilization of TCD screening for primary stroke prevention in children with sickle cell disease","volume":"72","author":"Armstrong-Wells","year":"2009","journal-title":"Neurology"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/pbc.24240","article-title":"Adherence to transcranial Doppler screening guidelines among children with sickle cell disease","volume":"60","author":"Eckrich","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/pbc.21430","article-title":"Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia","volume":"50","author":"McCarville","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pbc.21677","article-title":"A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: opportunities to improve healthcare quality","volume":"51","author":"Raphael","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3324\/haematol.10937","article-title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","volume":"92","author":"Telfer","year":"2007","journal-title":"Haematologica"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/blood-2004-02-0636","article-title":"Declining stroke rates in Californian children with sickle cell disease","volume":"104","author":"Fullerton","year":"2004","journal-title":"Blood"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1182\/blood-2011-03-337915","article-title":"Cervical carotid artery disease in sickle cell anemia: clinical and radiological features","volume":"118","author":"Telfer","year":"2011","journal-title":"Blood"},{"key":"R19-20230918","first-page":"1663","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial","volume":"377","author":"Ware","year":"2011","journal-title":"Lancet"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood-2006-11-057893","article-title":"Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia","volume":"110","author":"Zimmerman","year":"2007","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201610000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:04:35Z","timestamp":1695009875000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201610000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000633","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}